SCHEMBL2381883

SCHEMBL2381883

CC1(C)c2ccccc2-c2cc3cc4ccccc4c(-c4ccccc4)c3cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.39
GPR84 Q9NQS5 6/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
KDM4E B2RXH2 2/20 0.37
ESR1 P03372 3/20 0.35
ESR2 Q92731 3/20 0.35
HPGD P15428 3/20 0.34
LMNA P02545 1/20 0.34
CES1 P23141 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MAPT P10636 1/20 0.33
MPI P34949 1/20 0.33
RECQL P46063 1/20 0.33
ACHE P22303 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2380542 0.97 GPR84 (0.39) ALOX5GPR84MEN1KMT2AKDM4E
SCHEMBL2397945 0.92 ALOX5 (0.35) ALOX5GPR84MEN1KMT2AKDM4E
SCHEMBL2381317 0.92 ALOX5 (0.35) ALOX5GPR84MEN1KMT2AKDM4E
SCHEMBL2381040 0.90 ALOX5 (0.41) ALOX5GPR84HPGDCES1ALDH1A1
SCHEMBL2378791 0.88 GPR84 (0.40) ALOX5GPR84KDM4EESR1ESR2
SCHEMBL2381293 0.86 GPR84 (0.37) GPR84MEN1KMT2AKDM4EHPGD
SCHEMBL12186014 0.84 PDK2 (0.40) ALOX5MEN1KMT2AKDM4EHPGD
SCHEMBL5552172 0.82 ALOX5 (0.46) ALOX5GPR84CES1
SCHEMBL29702907 0.81 ALOX5 (0.42) ALOX5ESR1ESR2CES1
SCHEMBL2380509 0.80 ESR1 (0.40) MEN1KMT2AESR1ESR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8525158-B2 Anthracene derivative and organic electroluminescence element using the same DOOSAN CORPORATION (KR) 2013-09-03 US disclosed
US-20110210320-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME DOOSAN CORPORATION (KR) 2011-09-01 US disclosed
WO-2010027181-A2 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME 주식회사 두산 (KR) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110210320-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME KCNJ2, KCNJ1, BRD4 ALOX5 1930/4885GPR84 3669/4885MEN1 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.